-
Advances in PET settle debate over spread of key protein in Alzheimer’s
europeanpharmaceuticalreview
April 30, 2019
Advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer’s disease…
-
Medical cannabis significantly safer for elderly with chronic pain than opioids
europeanpharmaceuticalreview
April 30, 2019
Medical cannabis significantly safer for elderly with chronic pain than opioids.
-
Nicotinamide riboside repairs features of Alzheimer’s disease
europeanpharmaceuticalreview
April 30, 2019
Researchers have found that an NAD+ precursor helped mice with features of Alzheimer’s disease perform better on learning and memory tests…
-
For Obese People, Commuting by Car Can Be a Killer: Study
drugs
April 29, 2019
Being obese and commuting by car can be a deadly mix, a new study warns.
-
Using the Innate Immune System to Treat Disease
fiercebiotech
April 28, 2019
For most people, two of the most frightening diseases are cancer and Alzheimer’s disease. The reason is simple – these diseases are incurable.
-
CDC: First Confirmed ID of 'Kissing Bug' in Delaware
drugs
April 28, 2019
CDC: First Confirmed ID of 'Kissing Bug' in Delaware.
-
NIH scientists say advanced vaccines could limit future outbreaks
europeanpharmaceuticalreview
April 28, 2019
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID…
-
Antibiotic use increases risk of severe viral disease in mice
europeanpharmaceuticalreview
April 28, 2019
Killing gut bacteria with drugs weakens immune response…
-
LC-MS/MS used to identify novel prostaglandin-based compounds
europeanpharmaceuticalreview
April 28, 2019
Nitroproston is a novel prostaglandin-based compound with potential application in obstructive respiratory diseases…
-
IL-18 inhibitor drug holds great potential for inflammatory diseases
europeanpharmaceuticalreview
April 26, 2019
An international team of researchers has identified the key role that IL-18 protein plays in Still’s disease, making it a prime candidate for IL-18 inhibitor drug that is proving promising in current trials.